Switch to
More onapp

Bliss GVS Pharma Ltd

BLISSGVS
Health CarePharmaceuticals
SmallcapWith a market cap of ₹784 cr, stock is ranked 1,143
Moderate RiskStock is 2.31x as volatile as Nifty
75.500.05 (-0.07%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹784 cr, stock is ranked 1,143
Moderate RiskStock is 2.31x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
52.22
PB RatioPB Ratio
0.93
Dividend YieldDiv. Yield
0.66%
Sector PESector PE
35.81
Sector PBSector PB
4.37
Sector Div YldSctr Div Yld
0.90%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Bliss GVS Pharma Limited is engaged in developing, manufacturing and marketing pharmaceutical formulations.

Financial TrendFinancial statements 

2019202020212022936.20728.50597.43778.94123.7397.2668.5115.03
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 1.37%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Closure of trading window 
Announced OnSep 30, 2022

This is to inform you that pursuant to Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force) and in accordance with the Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, the Trading window for dealing in securities/shares of Bliss GVS Pharma Limited (¬タワthe Company¬タン) will remain closed for Insiders, Designated Persons and their immediate relatives of the Company with effect from Saturday, October 01, 2022 until 48 hours after the announcement of the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2022 | Download

This is to inform you that pursuant to Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force) and in accordance with the Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, the Trading window for dealing in securities/shares of Bliss GVS Pharma Limited (¬タワthe Company¬タン) will remain closed for Insiders, Designated Persons and their immediate relatives of the Company with effect from Saturday, October 01, 2022 until 48 hours after the announcement of the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2022 | Download

Loss of share certificate 
Announced OnSep 30, 2022

Bliss GVS Pharma Limited has informed the Exchange about Loss of share certificate Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for issue of duplicate share certificates consequent to loss of share certificates from the shareholder. | Download

Bliss GVS Pharma Limited has informed the Exchange about Loss of share certificate Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for issue of duplicate share certificates consequent to loss of share certificates from the shareholder. | Download

Cash Dividend 
Ex. DateJun 20, 2022

Final • Div/Share: ₹ 0.5

See all events